N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by (89)Zr-Trastuzumab and (18)F-FDG PET imaging

Trastuzumab remains an important drug in the management of human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer (BC). Several studies reported resistance mechanisms to trastuzumab, including impaired HER2-accessibility caused by mucin 4 (MUC4). Previously, we demonstrated an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wimana, Zéna, Gebhart, Geraldine, Guiot, Thomas, Vanderlinden, Bruno, Larsimont, Denis, Doumont, Gilles, Van Simaeys, Gaetan, Goldman, Serge, Flamen, Patrick, Ghanem, Ghanem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593554/
https://www.ncbi.nlm.nih.gov/pubmed/28915583
http://dx.doi.org/10.18632/oncotarget.17015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593554/
https://www.ncbi.nlm.nih.gov/pubmed/28915583
http://dx.doi.org/10.18632/oncotarget.17015

Ejemplares similares